A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity

被引：0

作者：

Eleftherios Kostaras

Teresa Kaserer

Glorianne Lazaro

Sara Farrah Heuss

Aasia Hussain

Pedro Casado

Angela Hayes

Cihangir Yandim

Nicolaos Palaskas

Yi Yu

Brian Schwartz

Florence Raynaud

Yuen-Li Chung

Pedro R. Cutillas

Igor Vivanco

机构：

[1] The Institute of Cancer Research,Division of Cancer Therapeutics

[2] The Institute of Cancer Research,Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics

[3] Center for Molecular Biosciences,Department of Pharmacology and Toxicology, Institute of Pharmacy

[4] University of Innsbruck,Centre for Haemato

[5] Queen Mary University of London,Oncology, Barts Cancer Institute

[6] David Geffen School of Medicine at UCLA,Division of Hematology and Oncology

[7] ArQule,Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging

[8] Inc. (a wholly-owned subsidiary of Merck & Co.,Department of Genetics and Bioengineering, Faculty of Engineering

[9] Inc.,undefined

[10] Kenilworth,undefined

[11] NJ,undefined

[12] USA),undefined

[13] The Institute of Cancer Research London and Royal Marsden Hospital,undefined

[14] Izmir University of Economics,undefined

来源：

British Journal of Cancer | 2020年 / 123卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：542 / 555

页数：13

共 50 条

[31] Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting Hexokinase-II
Liu, Ruijuan
Liu, Xuewei
MOLECULES, 2022, 27 (21):
[32] Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitors
Sun, Ying-Zhan
Wu, Jing-Wei
Du, Shan
Ma, Yang-Chun
Zhou, Liang
Ma, Ying
Wang, Run-Ling
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 92
[33] Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors
Abell, Andrew D.
Jones, Matthew A.
Coxon, James M.
Morton, James D.
Aitken, Steven G.
McNabb, Stephen B.
Lee, Hannah Y-Y
Mehrtens, Janna M.
Alexander, Nathan A.
Stuart, Blair G.
Neffe, Axel T.
Bickerstaff, Roy
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (08) : 1455 - 1458
[34] EVALUATION OF BIOLOGICAL ANALYSIS ACTIVITY - A SYSTEMATIC-APPROACH
ENEL, P
HADDAD, S
REVIRON, D
SANMARCO, JL
SYSTEM SCIENCE IN HEALTH CARE, 2: HEALTH CARE SYSTEM AND ACTORS, 1988, 139 : 399 - 402
[35] Synthesis and Biological Evaluation of a New Class of Myeloperoxidase Inhibitors
Rajagopal, Desikan
Parthasarathy, Sampath
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E60 - E60
[36] SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW SELECTIVE AROMATASE INHIBITORS
OKADA, M
YODEN, T
KAWAMINAMI, E
SHIMADA, Y
KUDO, M
FURUYA, T
ISOMURA, Y
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 148 - MEDI
[37] Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors
Uko, Nne E.
Guner, Osman F.
Barnett, Lillie M. A.
Matesic, Diane F.
Bowen, J. Phillip
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (19) : 3247 - 3250
[38] Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening
Liu, Guangpu
Jiao, Yang
Lin, Yongqiang
Hao, Haifang
Dou, Yanli
Yang, Juan
Jiang, Cheng-Shi
Chang, Ping
CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (02) : 161 - 166
[39] Molecular Pharmacologic approaches to functional analysis of new biological target molecules for drug discovery
Baba, Akemichi
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (10): : 1643 - 1654
[40] Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase
Tang, Huang
Wei, Yong-Biao
Zhang, Chi
Ning, Fang-Xian
Qiao, Wei
Huang, Shi-Liang
Ma, Lin
Huang, Zhi-Shu
Gu, Lian-Quan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) : 2523 - 2532

← 1 2 3 4 5 →